KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Cash from Financing Activities (2016 - 2025)

Jazz Pharmaceuticals has reported Cash from Financing Activities over the past 16 years, most recently at $75.4 million for Q4 2025.

  • Quarterly Cash from Financing Activities rose 1011.66% to $75.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$873.4 million through Dec 2025, down 4357.07% year-over-year, with the annual reading at -$873.4 million for FY2025, 4357.07% down from the prior year.
  • Cash from Financing Activities was $75.4 million for Q4 2025 at Jazz Pharmaceuticals, up from -$10.8 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $4.7 billion in Q2 2021 and troughed at -$813.5 million in Q1 2025.
  • The 5-year median for Cash from Financing Activities is -$67.5 million (2023), against an average of $114.1 million.
  • Biggest five-year swings in Cash from Financing Activities: crashed 1953.24% in 2021 and later soared 1011.66% in 2025.
  • Tracing JAZZ's Cash from Financing Activities over 5 years: stood at -$246.6 million in 2021, then surged by 107.95% to $19.6 million in 2022, then tumbled by 611.87% to -$100.3 million in 2023, then soared by 91.75% to -$8.3 million in 2024, then soared by 1011.66% to $75.4 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $75.4 million, -$10.8 million, and -$124.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.